Blend Labs Inc (NYSE: BLND): To Buy Or Not To Buy, That Is The Question

Blend Labs Inc (BLND) concluded trading on Wednesday at a closing price of $3.72, with 4.92 million shares of worth about $18.29 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 15.53% during that period and on January 15, 2025 the price saw a gain of about 8.14%. Currently the company’s common shares owned by public are about 252.13M shares, out of which, 208.21M shares are available for trading.

Stock saw a price change of -0.27% in past 5 days and over the past one month there was a price change of -26.77%. Year-to-date (YTD), BLND shares are showing a performance of -11.64% which increased to 54.36% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.08 but also hit the highest price of $5.53 during that period. The average intraday trading volume for Blend Labs Inc shares is 2.99 million. The stock is currently trading -9.72% below its 20-day simple moving average (SMA20), while that difference is down -17.73% for SMA50 and it goes to 8.28% higher than SMA200.

Blend Labs Inc (NYSE: BLND) currently have 252.13M outstanding shares and institutions hold larger chunk of about 43.41% of that.

The stock has a current market capitalization of $952.06M and its 3Y-monthly beta is at 1.41. It has posted earnings per share of -$0.34 in the same period. It has Quick Ratio of 3.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BLND, volatility over the week remained 5.97% while standing at 6.64% over the month.

Analysts are in expectations that Blend Labs Inc (BLND) stock would likely to be making an EPS of 0.01 in the current quarter, while forecast for next quarter EPS is 0.01 and it is 0.06 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.0 which is 0.01 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.09 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 82.96% while it is estimated to increase by 189.67% in next year. EPS is likely to grow at an annualized rate of 20.00% for next 5-years, compared to annual growth of -19.48% made by the stock over the past 5-years.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JMP Securities on December 18, 2024 offering a Mkt outperform rating for the stock and assigned a target price of $7 to it. Coverage by Canaccord Genuity stated Blend Labs Inc (BLND) stock as a Buy in their note to investors on August 12, 2024, suggesting a price target of $4.75 for the stock. On August 09, 2024, William Blair Upgrade their recommendations, while on December 20, 2023, Wells Fargo Upgrade their ratings for the stock with a price target of $3.50. Stock get a Mkt perform rating from Keefe Bruyette on November 14, 2022.

Most Popular

Related Posts